CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Axitinib

阿昔替尼 杂质对照品Axitinib Impurities

80 个杂质条目80 impurity entries

本页汇总 阿昔替尼 的 80 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 80 impurity reference standards of Axitinib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 阿昔替尼(Axitinib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 分析方法Analytical MethodsDevelopment and Validation of an LC-MS/MS Method for Simultaneous Quantification of Pazopanib, Cabozantinib, Sorafenib, Axitinib, Tivozanib, Sunitinib, and the Metabolites Sorafenib N-Oxide and Desethyl-Sunitinib in Human Plasma
    Pharmaceuticals (Basel, Switzerland) · 2026 · Greibe E et al.  ·  PMID 42653677  ·  DOI
  2. 分析方法Analytical MethodsDevelopment and validation of a bioanalytical method for the quantification of axitinib from plasma and capillary blood using volumetric absorptive microsampling (VAMS) and on-line solid phase extraction (SPE) LC-MS
    Journal of pharmaceutical and biomedical analysis · 2022 · Opitz P et al.  ·  PMID 36148722  ·  DOI
  3. 分析方法Analytical MethodsUPLC-MS/MS analysis of axitinib and pharmacokinetic application in beagle dogs
    Heliyon · 2024 · Bi H et al.  ·  PMID 39469690  ·  DOI
  4. 分析方法Analytical MethodsInvestigation of the effects of axitinib on the pharmacokinetics of loperamide and its main metabolite N-demethylated loperamide in rats by UPLC-MS/MS
    Chemico-biological interactions · 2019 · Lin QM et al.  ·  PMID 31299239  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisBromide-assisted chemoselective Heck reaction of 3-bromoindazoles under high-speed ball-milling conditions: synthesis of axitinib
    Beilstein journal of organic chemistry · 2018 · Yu J et al.  ·  PMID 29719575  ·  DOI

阿昔替尼 —— 原料药与杂质对照品Axitinib — drug substance & impurities

共 81 个条目(含原料药本体)81 items incl. the drug substance
Axitinib structure
原料药 APIAPI
阿昔替尼Axitinib
Axitinib
CAS No.319460-85-0
Chemical FormulaC22H18N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib N1-Glucuronide (M7) structure
—
Axitinib N1-Glucuronide (M7)
CAS No.—
Chemical FormulaC28H26N4O7S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Dimer structure
—
Axitinib Dimer
CAS No.—
Chemical FormulaC44H36N8O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib N2-Glucuronide structure
—
Axitinib N2-Glucuronide
CAS No.—
Chemical FormulaC28H26N4O7S
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso Axitinib structure
—
N-Nitroso Axitinib
CAS No.—
Chemical FormulaC22H17N5O2S
Purity>95%询价On request
10mg25mg50mg100mg
N-Nitroso-N-Methyl Axitinib structure
—
N-Nitroso-N-Methyl Axitinib
CAS No.—
Chemical FormulaC22H17N5O2S
Purity>95%询价On request
10mg25mg50mg100mg
N1,N2-di-Nitroso Axitinib structure
—
N1,N2-di-Nitroso Axitinib
CAS No.—
Chemical FormulaC22H16N6O3S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib N1 and N2-Glucuronide (Mixture of Isomers) structure
—
Axitinib N1 and N2-Glucuronide (Mixture of Isomers)
CAS No.—
Chemical FormulaC28H26N4O7S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 1 structure
1
阿昔替尼杂质52Axitinib Impurity 1
Axitinib Impurity 1
CAS No.885126-40-9
Chemical FormulaC22H18N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 2 structure
2
阿昔替尼杂质6Axitinib Impurity 2
Axitinib Impurity 2
CAS No.1428728-83-9
Chemical FormulaC44H36N8O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 3 structure
3
阿昔替尼杂质3Axitinib Impurity 3
Axitinib Impurity 3
CAS No.1528729-60-3
Chemical FormulaC30H24N6O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 4 structure
4
阿昔替尼杂质12Axitinib Impurity 4
Axitinib Impurity 4
CAS No.1443118-73-7
Chemical FormulaC22H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 5 structure
5
阿昔替尼杂质1Axitinib Impurity 5
Axitinib Impurity 5
CAS No.1347304-18-0
Chemical FormulaC22H18N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 6 structure
6
阿昔替尼杂质4Axitinib Impurity 6
Axitinib Impurity 6
CAS No.1443118-72-6
Chemical FormulaC29H25N5OS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 7 structure
7
阿昔替尼杂质2Axitinib Impurity 7
Axitinib Impurity 7
CAS No.1348536-59-3
Chemical FormulaC22H18N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 8 structure
8
阿昔替尼杂质7Axitinib Impurity 8
Axitinib Impurity 8
CAS No.944835-85-2
Chemical FormulaC15H13N3OS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 9 structure
9
阿昔替尼杂质8Axitinib Impurity 9
Axitinib Impurity 9
CAS No.885126-34-1
Chemical FormulaC15H12IN3OS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 10 structure
10
阿昔替尼杂质10Axitinib Impurity 10
Axitinib Impurity 10
CAS No.—
Chemical FormulaC22H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 11 structure
11
阿昔替尼杂质11Axitinib Impurity 11
Axitinib Impurity 11
CAS No.—
Chemical FormulaC15H12IN3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 12 structure
12
阿昔替尼杂质12Axitinib Impurity 12
Axitinib Impurity 12
CAS No.—
Chemical FormulaC22H18N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 13 structure
13
阿昔替尼杂质13Axitinib Impurity 13
Axitinib Impurity 13
CAS No.—
Chemical FormulaC21H15N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 14 structure
14
阿昔替尼杂质14Axitinib Impurity 14
Axitinib Impurity 14
CAS No.319462-34-5
Chemical FormulaC27H26N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 15 structure
15
阿昔替尼杂质15Axitinib Impurity 15
Axitinib Impurity 15
CAS No.1428728-84-0
Chemical FormulaC34H38N4O11S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 16 structure
16
阿昔替尼杂质16Axitinib Impurity 16
Axitinib Impurity 16
CAS No.—
Chemical FormulaC28H28N4O6S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 17 structure
17
阿昔替尼杂质17Axitinib Impurity 17
Axitinib Impurity 17
CAS No.—
Chemical FormulaC23H18N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 18 structure
18
阿昔替尼杂质18Axitinib Impurity 18
Axitinib Impurity 18
CAS No.—
Chemical FormulaC23H18N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 19 structure
19
阿昔替尼杂质19Axitinib Impurity 19
Axitinib Impurity 19
CAS No.—
Chemical FormulaC23H20N4OS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 20 structure
20
阿昔替尼杂质20Axitinib Impurity 20
Axitinib Impurity 20
CAS No.—
Chemical FormulaC28H24N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 21 structure
21
阿昔替尼杂质21Axitinib Impurity 21
Axitinib Impurity 21
CAS No.—
Chemical FormulaC22H18N4O3S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 22 structure
22
阿昔替尼杂质22Axitinib Impurity 22
Axitinib Impurity 22
CAS No.—
Chemical FormulaC22H18N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 23 structure
23
阿昔替尼杂质23Axitinib Impurity 23
Axitinib Impurity 23
CAS No.—
Chemical FormulaC22H18N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 24 structure
24
阿昔替尼杂质24Axitinib Impurity 24
Axitinib Impurity 24
CAS No.—
Chemical FormulaC22H18N4O5S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 26 structure
26
阿昔替尼杂质26Axitinib Impurity 26
Axitinib Impurity 26
CAS No.1959572-98-5
Chemical FormulaC24H24N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 27 structure
27
阿昔替尼杂质27Axitinib Impurity 27
Axitinib Impurity 27
CAS No.1639137-80-6
Chemical FormulaC19H18N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 28 structure
28
阿昔替尼杂质28Axitinib Impurity 28
Axitinib Impurity 28
CAS No.1959572-97-4
Chemical FormulaC44H36N8O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 29 structure
29
阿昔替尼杂质29Axitinib Impurity 29
Axitinib Impurity 29
CAS No.319472-78-1
Chemical FormulaC19H20N4O
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 31 structure
31
阿昔替尼杂质31Axitinib Impurity 31
Axitinib Impurity 31
CAS No.—
Chemical FormulaC44H34N8O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 32 structure
32
阿昔替尼杂质32Axitinib Impurity 32
Axitinib Impurity 32
CAS No.885126-35-2
Chemical FormulaC44H36N8O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 33 structure
33
阿昔替尼杂质30Axitinib Impurity 33
Axitinib Impurity 33
CAS No.2242852-05-5
Chemical FormulaC19H19N3O
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 34 structure
34
阿昔替尼杂质34Axitinib Impurity 34
Axitinib Impurity 34
CAS No.319463-51-9
Chemical FormulaC21H15N5O2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 35 structure
35
阿昔替尼杂质35Axitinib Impurity 35
Axitinib Impurity 35
CAS No.—
Chemical FormulaC21H17N5
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 36 structure
36
阿昔替尼杂质36Axitinib Impurity 36
Axitinib Impurity 36
CAS No.—
Chemical FormulaC21H15IN4
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 37 structure
37
阿昔替尼杂质37Axitinib Impurity 37
Axitinib Impurity 37
CAS No.—
Chemical FormulaC7H4N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 38 structure
38
阿昔替尼杂质38Axitinib Impurity 38
Axitinib Impurity 38
CAS No.—
Chemical FormulaC19H18N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 39 structure
39
阿昔替尼杂质39Axitinib Impurity 39
Axitinib Impurity 39
CAS No.—
Chemical FormulaC19H20N4O
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 40 structure
40
阿昔替尼杂质40Axitinib Impurity 40
Axitinib Impurity 40
CAS No.—
Chemical FormulaC19H18IN3O
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 41 structure
41
阿昔替尼杂质41Axitinib Impurity 41
Axitinib Impurity 41
CAS No.—
Chemical FormulaC14H9N5O3
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 42 structure
42
阿昔替尼杂质42Axitinib Impurity 42
Axitinib Impurity 42
CAS No.—
Chemical FormulaC24H24N6O6
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 43 structure
43
阿昔替尼杂质43Axitinib Impurity 43
Axitinib Impurity 43
CAS No.1348044-24-5
Chemical FormulaC14H8N6O4
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 44 structure
44
阿昔替尼杂质44Axitinib Impurity 44
Axitinib Impurity 44
CAS No.2571-90-6
Chemical FormulaC24H28N6O2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 45 structure
45
阿昔替尼杂质45Axitinib Impurity 45
Axitinib Impurity 45
CAS No.2527-66-4
Chemical FormulaC15H12IN3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 46 structure
46
阿昔替尼杂质46Axitinib Impurity 46
Axitinib Impurity 46
CAS No.6515-13-5
Chemical FormulaC22H18N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 47 structure
47
阿昔替尼杂质47Axitinib Impurity 47
Axitinib Impurity 47
CAS No.20054-45-9
Chemical FormulaC17H18N2O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 48 structure
48
阿昔替尼杂质48Axitinib Impurity 48
Axitinib Impurity 48
CAS No.886230-77-9
Chemical FormulaC19H21NO3S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 49 structure
49
阿昔替尼杂质49Axitinib Impurity 49
Axitinib Impurity 49
CAS No.261953-36-0
Chemical FormulaC7H6IN3
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 50 structure
50
阿昔替尼杂质39Axitinib Impurity 50
Axitinib Impurity 50
CAS No.1443118-75-9
Chemical FormulaC23H20N4O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 51 structure
51
阿昔替尼杂质51Axitinib Impurity 51
Axitinib Impurity 51
CAS No.—
Chemical FormulaC14H11N7
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 52 structure
52
阿昔替尼杂质52Axitinib Impurity 52
Axitinib Impurity 52
CAS No.—
Chemical FormulaC14H10N6O
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 53 structure
53
阿昔替尼杂质53Axitinib Impurity 53
Axitinib Impurity 53
CAS No.—
Chemical FormulaC14H10N6
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 54 structure
54
阿昔替尼杂质54Axitinib Impurity 54
Axitinib Impurity 54
CAS No.886230-75-7
Chemical FormulaC14H12N6
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 55 structure
55
阿昔替尼杂质55Axitinib Impurity 55
Axitinib Impurity 55
CAS No.13959-34-7
Chemical FormulaC7H7N3
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 56 structure
56
阿昔替尼杂质114Axitinib Impurity 56
Axitinib Impurity 56
CAS No.13959-33-6
Chemical FormulaC8H9N
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 57 structure
57
阿昔替尼杂质115Axitinib Impurity 57
Axitinib Impurity 57
CAS No.1122-70-9
Chemical FormulaC8H9N
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 58 structure
58
阿昔替尼杂质116Axitinib Impurity 58
Axitinib Impurity 58
CAS No.3883-39-4
Chemical FormulaC8H9N
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 59 structure
59
阿昔替尼杂质59Axitinib Impurity 59
Axitinib Impurity 59
CAS No.13959-26-7
Chemical FormulaC17H15N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 60 structure
60
阿昔替尼杂质60Axitinib Impurity 60
Axitinib Impurity 60
CAS No.87511-99-7
Chemical FormulaC22H18N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 61 structure
61
阿昔替尼杂质61Axitinib Impurity 61
Axitinib Impurity 61
CAS No.1824099-80-0
Chemical FormulaC16H13N3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 62 structure
62
阿昔替尼杂质62Axitinib Impurity 62
Axitinib Impurity 62
CAS No.1824338-82-0
Chemical FormulaCH4N2O
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 64 structure
64
阿昔替尼杂质64Axitinib Impurity 64
Axitinib Impurity 64
CAS No.1639138-00-3
Chemical FormulaC17H14IN3O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 67 structure
67
阿昔替尼杂质67Axitinib Impurity 67
Axitinib Impurity 67
CAS No.19602-82-5
Chemical FormulaC14H8Cl2O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 68 structure
68
阿昔替尼杂质68Axitinib Impurity 68
Axitinib Impurity 68
CAS No.36506-51-1
Chemical FormulaC5H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 82 structure
82
阿昔替尼杂质82Axitinib Impurity 82
Axitinib Impurity 82
CAS No.1253568-66-9
Chemical FormulaC12H13N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 86 structure
86
阿昔替尼杂质86Axitinib Impurity 86
Axitinib Impurity 86
CAS No.2527-58-4
Chemical FormulaC16H16N2O2S2
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 87 structure
87
阿昔替尼杂质87Axitinib Impurity 87
Axitinib Impurity 87
CAS No.2519453-47-3
Chemical FormulaC22H18N4O4S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 88 structure
88
阿昔替尼杂质88Axitinib Impurity 88
Axitinib Impurity 88
CAS No.5697-20-1
Chemical FormulaC7H7NOS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 91 structure
91
阿昔替尼杂质91Axitinib Impurity 91
Axitinib Impurity 91
CAS No.3724-10-5
Chemical FormulaC8H8O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 92 structure
92
阿昔替尼杂质92Axitinib Impurity 92
Axitinib Impurity 92
CAS No.4337-43-3
Chemical FormulaC7H4ClNOS
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 96 structure
96
阿昔替尼杂质96Axitinib Impurity 96
Axitinib Impurity 96
CAS No.2419145-29-0
Chemical FormulaC7H7N3O
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 97 structure
97
阿昔替尼杂质97Axitinib Impurity 97
Axitinib Impurity 97
CAS No.1349772-83-3
Chemical FormulaC22H18N4O2S
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 98 structure
98
阿昔替尼杂质98Axitinib Impurity 98
Axitinib Impurity 98
CAS No.2768128-52-3
Chemical FormulaC14H11N5
Purity>95%询价On request
10mg25mg50mg100mg
Axitinib Impurity 110 structure
110
阿昔替尼杂质110Axitinib Impurity 110
Axitinib Impurity 110
CAS No.885522-11-2
Chemical FormulaC7H5IN2
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

阿昔替尼 —— 研究文献与合成路线Axitinib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 阿昔替尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Axitinib. Titles link to the original records; copyright remains with the authors and publishers.

合成路线文献Synthetic-route papers

  1. Design, Synthesis, and Biological Evaluation of Axitinib Derivatives
    Wei N, Liang J, Peng S, et al. · Molecules (Basel, Switzerland) · 2018
  2. Bromide-assisted chemoselective Heck reaction of 3-bromoindazoles under high-speed ball-milling conditions: synthesis of axitinib
    Yu J, Hong Z, Yang X, et al. · Beilstein journal of organic chemistry · 2018
  3. Axitinib induces paradoxical erythropoietin synthesis in metastatic renal cell carcinoma
    Alexandre I, Billemont B, Meric JB, et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2009

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

阿昔替尼 杂质谱研究要点Axitinib — impurity profiling notes

下面这些是拿到 阿昔替尼 的 81 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 81 impurity entries for Axitinib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances